Biomedical applications of functionalized hollow mesoporous silica nanoparticles: Focusing on molecular imaging

Nanomedicine

Volumn 8, Issue 12, 2013, Pages 2027-2039

  Shi, Sixiang ^a   Chen, Feng ^a   Cai, Weibo ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

cancer; hollow mesoporous silica nanoparticle; molecular imaging; nanomedicine; optical imaging; PET; theranostics

Indexed keywords

DOXORUBICIN; ENDOGLIN; FLUORESCEIN ISOTHIOCYANATE; FUNCTIONALIZED HOLLOW MESOPOROUS SILICA NANOPARTICLE; HOLLOW MESOPOROUS SILICA NANOPARTICLE; IRON OXIDE; NANOCRYSTAL; NANOPARTICLE; PERFLEXANE; QUANTUM DOT; UNCLASSIFIED DRUG; UPCONVERSION NANOPARTICLE;

CANCER THERAPY; DRUG DELIVERY SYSTEM; ELECTRON DIFFRACTION; FLUORESCENCE IMAGING; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MOLECULAR IMAGING; NANOENGINEERING; NANOMEDICINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND;

ANIMALS; HUMANS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NEOPLASMS; OPTICAL IMAGING; POROSITY; POSITRON-EMISSION TOMOGRAPHY; SILICON DIOXIDE; ULTRASONOGRAPHY;

EID: 84889590194     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.177     Document Type: Review

References (89)

1. Cabral H, Nishiyama N, Kataoka K. Supramolecular nanodevices: From design validation to theranostic nanomedicine. Acc. Chem. Res. 44(10), 999-1008 (2011
2. Ma X, Zhao Y, Liang XJ. Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc. Chem. Res. 44(10), 1114-1122 (2011
3. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 3(11), 1840-1854 (2007 (Pubitemid 350099850)
4. Tang FQ, Li LL, Chen D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv. Mater. 24(12), 1504-1534 (2012
5. Vivero-Escoto JL, Huxford-Phillips RC, Lin W. Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem. Soc. Rev. 41(7), 2673-2685 (2012
6. Benezra M, Penate-Medina O, Zanzonico PB et al. Multimodal silica nanoparticles are effective cancer-Targeted probes in a model of human melanoma. J. Clin. Invest. 121(7), 2768-2780 (2011
7. Tarn D, Ashley CE, Xue M, Carnes EC, Zink JI, Brinker CJ. Mesoporous silica nanoparticle nanocarriers: Biofunctionality and biocompatibility. Acc. Chem. Res. 46(3), 792-801 (2013
8. Vallet-Regi M, Rámila A, del Real RP, Pérez Pariente J. A new property of MCM-41: Drug delivery system. Chem. Mater. 13(2), 308-311 (2000
9. Li YS, Shi JL, Hua ZL, Chen HR, Ruan ML, Yan DS Hollow spheres of mesoporous aluminosilicate with a three-dimensional pore network and extraordinarily high hydrothermal stability. Nano Lett. 3(5), 609-612 (2003
10. Han L, Gao C, Wu X et al. Anionic surfactants templating route for synthesizing silica hollow spheres with different shell porosity. Solid State Sci. 13(4), 721-728 (2011
11. Wu XJ, Xu D. Formation of yolk/SiO2 shell structures using surfactant mixtures as template. J. Am. Chem. Soc. 131(8), 2774-2775 (2009
12. Wu XJ, Xu DS. Soft template synthesis of yolk/silica shell particles. Adv. Mater. 22(13), 1516-1520 (2010
13. Liu J, Qiao SZ, Hartono SB, Lu GQ. Monodisperse yolk-shell nanoparticles with a hierarchical porous structure for delivery vehicles and nanoreactors. Angew. Chem. Int. Ed. Engl. 49(29), 4981-4985 (2010
14. Yang G, Gai S, Qu F, Yang P. SiO2@ YBO3:Eu3+ hollow mesoporous spheres for drug delivery vehicle. ACS Appl. Mater. Interfaces 5(12), 5788-5796 (2013
15. Chen Y, Chen H, Shi J. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv. Mater. 25(23), 3144-3176 (2013
16. Chen D, Li LL, Tang FQ, Qi SO. Facile and scalable synthesis of tailored silica nanorattle structures. Adv. Mater. 21(37), 3804-3807 (2009
17. Zhang LY, Wang TT, Yang L et al. General route to multifunctional uniform yolk/ mesoporous silica shell nanocapsules: A platform for simultaneous cancer-Targeted imaging and magnetically guided drug delivery. Chem. Eur. J. 18(39), 12512-12521 (2012
18. Fang XL, Zhao XJ, Fang WJ, Chen C, Zheng NF. Self-Templating synthesis of hollow mesoporous silica and their applications in catalysis and drug delivery. Nanoscale 5(6), 2205-2218 (2013
19. Chen Y, Chen HR, Guo LM et al. Hollow/rattle-Type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 4(1), 529-539 (2010
20. Wong YJ, Zhu L, Teo WS et al. Revisiting the Stöber method: Inhomogeneity in silica shells. J. Am. Chem. Soc. 133(30), 11422-11425 (2011
21. Kim J, Kim HS, Lee N et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. Engl. 47(44), 8438-8441 (2008
22. Zhang Q, Zhang TR, Ge JP, Yin YD Permeable silica shell through surface protected etching. Nano Lett. 8(9), 2867-2871 (2008
23. Fang X, Chen C, Liu Z, Liu P, Zheng N. A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres. Nanoscale 3(4), 1632-1639 (2011
24. Ren N, Wang B, Yang YH et al. General method for the fabrication of hollow microcapsules with adjustable shell compositions. Chem. Mater. 17(10), 2582-2587 (2005 (Pubitemid 40749299)
25. Zhang Q, Ge JP, Goebl J, Hu YX, Lu ZD, Yin YD. Rattle-Type silica colloidal particles prepared by a surface-protected etching process. Nano Res. 2(7), 583-591 (2009
26. Hu Y, Zhang Q, Goebl J, Zhang T, Yin Y. Control over the permeation of silica nanoshells by surface-protected etching with water. Phys. Chem. Chem. Phys. 12(38), 11836-11842 (2010
27. Chen Y, Chen HR, Zeng DP et al. Core/shell structured hollow mesoporous nanocapsules: A potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 4(10), 6001-6013 (2010
28. Chen Y, Chen H, Sun Y et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew. Chem. Int. Ed. Engl. 50(52), 12505-12509 (2011
29. Chen Y, Chen H, Zhang S et al. Structure property relationships in manganese oxide-mesoporous silica nanoparticles used for T1 weighted MRI and simultaneous anti-cancer drug delivery. Biomaterials 33(7), 2388-2398 (2012
30. Ma M, Chen H, Chen Y et al. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-Therapy and multimodal imaging. Biomaterials 33(3), 989-998 (2012
31. Wang X, Chen H, Zheng Y et al. Au nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation. Biomaterials 34(8), 2057-2068 (2013
32. Chen Y, Chen H, Zhang S et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv. Funct. Mater. 21(2), 270-278 (2011
33. Mankoff DA. A definition of molecular imaging. J. Nucl. Med. 48(6), 18N-21N (2007
34. Nolting DD, Nickels ML, Guo N, Pham W. Molecular imaging probe development: A chemistry perspective. Am. J. Nucl. Med. Mol. Imaging 2(3), 273-306 (2012
35. James ML, Gambhir SS. A molecular imaging primer: Modalities, imaging agents, and applications. Physiol. Rev. 92(2), 897-965 (2012
36. Gao Y, Cui Y, Chan JK, Xu C. Stem cell tracking with optically active nanoparticles. Am. J. Nucl. Med. Mol. Imaging 3(3), 232-246 (2013
37. Wu Y, Zhang W, Li J, Zhang Y. Optical imaging of tumor microenvironment. Am. J. Nucl. Med. Mol. Imaging 3(1), 1-15 (2013
38. Erathodiyil N, Ying JY. Functionalization of inorganic nanoparticles for bioimaging applications. Acc. Chem. Res. 44(10), 925-935 (2011
39. Wang K, He X, Yang X, Shi H. Functionalized silica nanoparticles: A platform for fluorescence imaging at the cell and small animal levels. Acc. Chem. Res. 46(7), 1367-1376 (2013
40. Huang CC, Huang W, Yeh CS. Shell-by-shell synthesis of multi-shelled mesoporous silica nanospheres for optical imaging and drug delivery. Biomaterials 32(2), 556-564 (2011
41. Fan WP, Shen B, Bu WB et al. Rattle structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual mode imaging. J. Am. Chem. Soc. 135(17), 6494-6503 (2013
42. Zhang F, Braun GB, Pallaoro A et al. Mesoporous multifunctional upconversion luminescent and magnetic nanorattle materials for targeted chemotherapy. Nano Lett. 12(1), 61-67 (2012
43. Thukkani AK, Jaffer FA. Intravascular near infrared fluorescence molecular imaging of atherosclerosis. Am. J. Nucl. Med. Mol. Imaging 3(3), 217-231 (2013
44. Zhang Y, Hong H, Engle JW, Yang Y, Barnhart TE, Cai W. Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am. J. Nucl. Med. Mol. Imaging 2(1), 1-13 (2012
45. Pan J, Wan D, Gong J. PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging. Chem. Commun. 47(12), 3442-3444 (2011
46. Derfus AM, Chan WCW, Bhatia SN Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 4(1), 11-18 (2003
47. Cai W, Hong H. In a nutshell: Intrinsically radio-labeled quantum dots. Am. J. Nucl. Med. Mol. Imaging 2(2), 136-140 (2012
48. Xiong L, Yang T, Yang Y, Xu C, Li F. Long term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 31(27), 7078-7085 (2010
49. Haase M, Schafer H. Upconverting nanoparticles. Angew. Chem. Int. Ed. Engl. 50(26), 5808-5829 (2011
50. Wu S, Han G, Milliron DJ et al. Non blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals. Proc. Natl Acad. Sci. USA 106(27), 10917-10921 (2009
51. Cheng L, Wang C, Liu Z. Upconversion nanoparticles and their composite nanostructures for biomedical imaging and cancer therapy. Nanoscale 5(1), 23-37 (2012
52. Chatterjee DK, Rufaihah AJ, Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29(7), 937-943 (2008 (Pubitemid 350266053)
53. Xiong L, Chen Z, Tian Q, Cao T, Xu C, Li F. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Anal. Chem. 81(21), 8687-8694 (2009
54. Wang F, Liu X. Upconversion multicolor fine tuning: Visible to near-infrared emission from lanthanide-doped NaYF4 nanoparticles. J. Am. Chem. Soc. 130(17), 5642-5643 (2008 (Pubitemid 351600484)
55. Zhou J, Liu Z, Li F. Upconversion nanophosphors for small-Animal imaging. Chem. Soc. Rev. 41(3), 1323-1349 (2012
56. Alauddin MM. Positron emission tomography (PET) imaging with 18F-based radiotracers. Am. J. Nucl. Med. Mol. Imaging 2(1), 55-76 (2012
57. Fakhri GE. Ready for prime time? Dual tracer PET and SPECT imaging. Am. J. Nucl. Med. Mol. Imaging 2(4), 415-417 (2012
58. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2(9), 683-693 (2002 (Pubitemid 37328919)
59. Temma T, Saji H. Radiolabelled probes for imaging of atherosclerotic plaques. Am. J. Nucl. Med. Mol. Imaging 2(4), 432-447 (2012
60. Holland JP, Cumming P, Vasdev N. PET radiopharmaceuticals for probing enzymes in the brain. Am. J. Nucl. Med. Mol. Imaging 3(3), 194-216 (2013
61. Hong H, Zhang Y, Sun J, Cai W. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 4(5), 399-413 (2009
62. Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J. Nucl. Med. 49(Suppl. 2), 113S-128S (2008 (Pubitemid 351948040)
63. Shi S, Yang K, Hong H et al. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials 34(12), 3002-3009 (2013
64. Hong H, Yang K, Zhang Y et al. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 6(3), 2361-2370 (2012
65. Xiao Y, Hong H, Javadi A et al. Multifunctional unimolecular micelles for cancer-Targeted drug delivery and positron emission tomography imaging. Biomaterials 33(11), 3071-3082 (2012
66. Seon BK, Haba A, Matsuno F et al. Endoglin targeted cancer therapy. Curr. Drug. Deliv. 8(1), 135-143 (2011
67. Fonsatti E, Nicolay HJ, Altomonte M, Covre A, Maio M. Targeting cancer vasculature via endoglin/CD105: A novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc. Res. 86(1), 12-19 (2010
68. Rosen LS, Hurwitz HI, Wong MK et al. A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer. Clin. Cancer Res. 18(17), 4820-4829 (2012
69. Hong H, Severin GW, Yang Y et al. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. Eur. J. Nucl. Med. Mol. Imaging 39(1), 138-148 (2012
70. Hong H, Yang Y, Zhang Y et al. Positron emission tomography imaging of CD105 expression during tumor angiogenesis. Eur. J. Nucl. Med. Mol. Imaging 38(7), 1335-1343 (2011
71. Villaraza AJ, Bumb A, Brechbiel MW. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: The interplay between size, function, and pharmacokinetics. Chem. Rev. 110(5), 2921-2959 (2010
72. Balyasnikova S, Löfgren J, de Nijs R, Zamogilnaya Y, Højgaard L, Fischer BM. PET/MR in oncology: An introduction with focus on MR and future perspectives for hybrid imaging. Am. J. Nucl. Med. Mol. Imaging 2(4), 458-474 (2012
73. Ripa RS, Knudsen A, Hag AM et al. Feasibility of simultaneous PET/MR of the carotid artery: First clinical experience and comparison to PET/CT. Am. J. Nucl. Med. Mol. Imaging 3(4), 361-371 (2013
74. Chen Y, Yin Q, Ji X et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 33(29), 7126-7137 (2012
75. Gandhi S, Sethuraman S, Krishnan UM. Synthesis, characterization and biocompatibility evaluation of iron oxide incorporated magnetic mesoporous silica. Dalton Trans. 41(40), 12530-12537 (2012
76. Liu HM, Wu SH, Lu CW et al. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. Small 4(5), 619-626 (2008
77. Ye F, Laurent S, Fornara A et al. Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T2 contrast agent with tunable proton relaxivities. Contrast Media Mol. Imaging 7(5), 460-468 (2012
78. Zhang L, Wang Y, Tang Y et al. High MRI performance fluorescent mesoporous silica-coated magnetic nanoparticles for tracking neural progenitor cells in an ischemic mouse model. Nanoscale 5(10), 4506-4516 (2013
79. Pan D, Caruthers SD, Senpan A, Schmieder AH, Wickline SA, Lanza GM. Revisiting an old friend: Manganese-based MRI contrast agents. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3, 162-173 (2011
80. Behera D, Behera S, Jacobs KE, Biswal S. Bilateral peripheral neural activity observed in vivo following unilateral nerve injury. Am. J. Nucl. Med. Mol. Imaging 3(3), 282-290 (2013
81. Kim T, Momin E, Choi J et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose derived mesenchymal stem cells. J. Am. Chem. Soc. 133(9), 2955-2961 (2011
82. Na HB, Lee JH, An K et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew. Chem. Int. Ed. Engl. 46(28), 5397-5401 (2007 (Pubitemid 47067643)
83. Azhari H. Ultrasound: Medical imaging and beyond (an invited review). Curr. Pharm. Biotechnol. 13(11), 2104-2116 (2012
84. Wang X, Chen H, Chen Y et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv. Mater. 24(6), 785-791 (2012
85. Chen Y, Gao Y, Chen H et al. Engineering inorganic nanoemulsions/ nanoliposomes by fluoride-silica chemistry for efficient delivery/co-delivery of hydrophobic agents. Adv. Funct. Mater. 22(8), 1586-1597 (2012
86. Wang CY, Yang CH, Lin YS, Chen CH, Huang KS. Anti-inflammatory effect with high intensity focused ultrasound-mediated pulsatile delivery of diclofenac. Biomaterials 33(5), 1547-1553 (2012
87. Fang WJ, Tang SH, Liu PX, Fang XL, Gong JW, Zheng NF. Pd nanosheet-covered hollow mesoporous silica nanoparticles as a platform for the chemo-photothermal treatment of cancer cells. Small 8(24), 3816-3822 (2012
88. Li LL, Tang FQ, Liu HY et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano 4(11), 6874-6882 (2010
89. Liu H, Liu T, Wu X et al. Targeting gold nanoshells on silica nanorattles: A drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light. Adv. Mater. 24(6), 755-761 (2012